| Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial (NCT04814030) | Sun Yat-sen University | 2021-04-20 |
| KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial (NCT04844619) | Sun Yat-sen University | 2021-04-19 |
| Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses (NCT05114707) | Sun Yat-sen University | 2021-04-16 |
| Sintilimab in Combination With Chidamide in Refractory and Relapsed AITL (NCT04831710) | Sun Yat-sen University | 2021-04-15 |
| Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study (NCT04850235) | Sun Yat-sen University | 2021-04-15 |
| Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC (NCT04833257) | Sun Yat-sen University | 2021-04-14 |
| R2-CHOP in Untreated DEL-DLBCL：An Open-lable，Multicenter，Phase II Study (NCT04842487) | Sun Yat-sen University | 2021-04-10 |
| Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI (NCT04829019) | Sun Yat-sen University | 2021-04-07 |
| Effects of Diet and Exercise Interventions on Cardiometabolic Risk Markers, Executive Function, and Intestinal Flora (NCT04834687) | Sun Yat-sen University | 2021-04-02 |
| Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors (NCT06015802) | Sun Yat-sen University | 2021-04-01 |
| Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC (NCT04826679) | Sun Yat-sen University | 2021-04-01 |
| Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma (NCT04797182) | Sun Yat-sen University | 2021-04-01 |
| PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL (NCT04624984) | Sun Yat-sen University | 2021-04-01 |
| Analysis of Hospitalization Data From ZOC (NCT04890496) | Sun Yat-sen University | 2021-03-18 |
| A Platform for Multidisciplinary Medical Artificial Intelligence Development (NCT04890847) | Sun Yat-sen University | 2021-03-18 |
| Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical Cancer (NCT04799639) | Sun Yat-sen University | 2021-03-18 |
| Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma (NCT04724239) | Sun Yat-sen University | 2021-03-11 |
| Topotecan and Melphalan for Retinoblastoma (NCT04799002) | Sun Yat-sen University | 2021-03-11 |
| Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma (NCT04423536) | Sun Yat-sen University | 2021-03-09 |
| Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma (NCT04778956) | Sun Yat-sen University | 2021-03-03 |
| Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma (NCT06199297) | Sun Yat-sen University | 2021-03-02 |
| A Clinical Trial of Esophagectomy for Esophageal Carcinoma (NCT06691503) | Sun Yat-sen University | 2021-03-01 |
| Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML (NCT04254640) | Sun Yat-sen University | 2021-03-01 |
| Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty Liver (NCT05076058) | Sun Yat-sen University | 2021-03-01 |
| Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction (NCT06069232) | Sun Yat-sen University | 2021-03-01 |
| Office Based Vergence/Accommodative Therapy for the Treatment of Intermittent Exotropia (NCT04744779) | Sun Yat-sen University | 2021-03-01 |
| Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant Metastasis (NCT04769908) | Sun Yat-sen University | 2021-02-23 |
| Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (NCT04844385) | Sun Yat-sen University | 2021-02-20 |
| Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA) (NCT04777942) | Sun Yat-sen University | 2021-02-20 |
| TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites (NCT04640116) | Sun Yat-sen University | 2021-02-01 |
| The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma (NCT04762745) | Sun Yat-sen University | 2021-02-01 |
| Lymphadenectomy in Early Ovarian Cancer (NCT04710797) | Sun Yat-sen University | 2021-01-31 |
| Zanubrutinib-based Induction and Maintenance Therapy in Young and Fit Patients With Untreated Mantle Cell Lymphoma (NCT04736914) | Sun Yat-sen University | 2021-01-31 |
| Monitoring Minimal Residual Disease（MRD）in Pediatric B-acute Lymphoblastic Leukemia (NCT04977895) | Sun Yat-sen University | 2021-01-30 |
| A Single-center, Single-arm Clinical Study Evaluating the Short-term Efficacy of Inflatable Mediastinoscopic-assisted Transhiatal Laparoscopic Esophagectomy for the Radical Resection of Thoracic Esophageal Cancer (NCT07581236) | Sun Yat-sen University | 2021-01-27 |
| Development of AI Model for Uveitis Progression and Prognosis (NCT04705103) | Sun Yat-sen University | 2021-01-10 |
| Deep Learning Model for Diagnosis and Contour of Cervical Lymph Node for Nasopharyngeal Carcinoma (NCT05231616) | Sun Yat-sen University | 2021-01-05 |
| Submucosal Saline Injection Followed by Endoscopic Ultrasound (NCT06022978) | Sun Yat-sen University | 2021-01-01 |
| HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT (NCT04618367) | Sun Yat-sen University | 2021-01-01 |
| PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced pMMR/MSS Rectal Cancer (NCT04833387) | Sun Yat-sen University | 2021-01-01 |
| Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma (NCT04562311) | Sun Yat-sen University | 2021-01-01 |
| HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma (NCT06333561) | Sun Yat-sen University | 2021-01-01 |
| HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama (NCT04627363) | Sun Yat-sen University | 2021-01-01 |
| Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma (NCT06323382) | Sun Yat-sen University | 2021-01-01 |
| Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy (NCT07309991) | Sun Yat-sen University | 2021-01-01 |
| Almonertinib Combined With Pyrotinib in the Treatment of Advanced NSCLC Patients With HER-2 Amplification/Mutation After EGFR-TKI Resistance (NCT04785729) | Sun Yat-sen University | 2020-12-31 |
| Almonertinib for Advanced NSCLC Patients With Rare Mutations in EGFR (NCT04785742) | Sun Yat-sen University | 2020-12-31 |
| Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial (NCT04687163) | Sun Yat-sen University | 2020-12-30 |
| Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study (NCT04680598) | Sun Yat-sen University | 2020-12-25 |
| Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cm (NCT04686942) | Sun Yat-sen University | 2020-12-17 |
| Ablation Combined With PD-1 in HCC: Phase II Study (NCT04652440) | Sun Yat-sen University | 2020-12-15 |
| Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China (NCT04334330) | Sun Yat-sen University | 2020-12-04 |
| Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection (NCT04682210) | Sun Yat-sen University | 2020-12-01 |
| Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiotherapy (NCT04654234) | Sun Yat-sen University | 2020-12-01 |
| Quantitatively Analysis of Fundus Structure Characteristics in Glaucoma Following Congenital Cataract Surgery (NCT05446077) | Sun Yat-sen University | 2020-12-01 |
| Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC (NCT04682249) | Sun Yat-sen University | 2020-12-01 |
| Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC (NCT04615143) | Sun Yat-sen University | 2020-12-01 |
| Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCL (NCT04624958) | Sun Yat-sen University | 2020-12-01 |
| Accuracy of Digital Implant Impression (NCT04627649) | Sun Yat-sen University | 2020-12-01 |
| PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer (NCT04715633) | Sun Yat-sen University | 2020-12-01 |
| Effect of Prebiotics on Blood Glucose Management (NCT04636489) | Sun Yat-sen University | 2020-11-30 |
| Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NCT04636632) | Sun Yat-sen University | 2020-11-24 |
| JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma (NCT05173246) | Sun Yat-sen University | 2020-11-17 |
| Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor. (NCT04581265) | Sun Yat-sen University | 2020-11-10 |
| Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer (NCT04651127) | Sun Yat-sen University | 2020-11-09 |
| A Study of Radiotherapy Planning System Software ---- Zeus Cloud (NCT04579718) | Sun Yat-sen University | 2020-11-01 |
| Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma (NCT05080010) | Sun Yat-sen University | 2020-11-01 |
| PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients (NCT04711434) | Sun Yat-sen University | 2020-11-01 |
| Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer (NCT04539600) | Sun Yat-sen University | 2020-11-01 |
| Real-time Artificial Intelligence System for Detecting Multiple Ocular Fundus Lesions by Ultra-widefield Fundus Imaging (NCT04859634) | Sun Yat-sen University | 2020-11-01 |
| A Novel Prognostic Model of NPI for Risk-Predicting and Clinical Decision-making in Diffuse Large B-Cell Lymphoma in the Rituximab Era (NCT04624971) | Sun Yat-sen University | 2020-11-01 |
| The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study (NCT07272265) | Sun Yat-sen University | 2020-10-28 |
| Toripalimab Combined With CAV/IE Regimen (NCT04589741) | Sun Yat-sen University | 2020-10-23 |
| Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma (NCT04606108) | Sun Yat-sen University | 2020-10-19 |
| Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors. (NCT05072327) | Sun Yat-sen University | 2020-10-15 |
| Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy (NCT04547829) | Sun Yat-sen University | 2020-10-10 |
| Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma (NCT04588987) | Sun Yat-sen University | 2020-10-01 |
| Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study (NCT04536558) | Sun Yat-sen University | 2020-10-01 |
| A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor (NCT05561036) | Sun Yat-sen University | 2020-09-29 |
| VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma (NCT03641456) | Sun Yat-sen University | 2020-09-25 |
| Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC (NCT04507217) | Sun Yat-sen University | 2020-09-15 |
| Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and Chemoradiotherapy (NCT04507035) | Sun Yat-sen University | 2020-09-01 |
| Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT04548271) | Sun Yat-sen University | 2020-09-01 |
| Eye Movement and Cognitive Dysfunction (NCT04236375) | Sun Yat-sen University | 2020-09-01 |
| Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection (NCT03990974) | Sun Yat-sen University | 2020-09-01 |
| Camrelizumab Combined With Apatinib in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT04547088) | Sun Yat-sen University | 2020-09-01 |
| Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma (NCT04453826) | Sun Yat-sen University | 2020-09-01 |
| A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiation (NCT04534855) | Sun Yat-sen University | 2020-09-01 |
| A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in China (NCT04538651) | Sun Yat-sen University | 2020-08-31 |
| Prognostic Nomogram of Extranodal NK/T-cell Lymphoma (NCT04554511) | Sun Yat-sen University | 2020-08-28 |
| Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR) (NCT06524427) | Sun Yat-sen University | 2020-08-25 |
| Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma (NCT04448522) | Sun Yat-sen University | 2020-08-18 |
| Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma (NCT04456322) | Sun Yat-sen University | 2020-08-17 |
| TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer (NCT04475016) | Sun Yat-sen University | 2020-08-12 |
| Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors (NCT04400851) | Sun Yat-sen University | 2020-08-11 |
| Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial (NCT04502641) | Sun Yat-sen University | 2020-08-01 |
| Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study (NCT04454905) | Sun Yat-sen University | 2020-08-01 |
| PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer (NCT04301557) | Sun Yat-sen University | 2020-07-31 |
| Using Machine Learning to Adapt Visual Aids for Patients With Low Vision (NCT04892316) | Sun Yat-sen University | 2020-07-27 |
| Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer (NCT04790448) | Sun Yat-sen University | 2020-07-27 |